Blanche Schroen

7.9k total citations · 3 hit papers
63 papers, 5.5k citations indexed

About

Blanche Schroen is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Cancer Research. According to data from OpenAlex, Blanche Schroen has authored 63 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Molecular Biology, 34 papers in Cardiology and Cardiovascular Medicine and 34 papers in Cancer Research. Recurrent topics in Blanche Schroen's work include MicroRNA in disease regulation (21 papers), Cancer-related molecular mechanisms research (17 papers) and Cardiac Fibrosis and Remodeling (11 papers). Blanche Schroen is often cited by papers focused on MicroRNA in disease regulation (21 papers), Cancer-related molecular mechanisms research (17 papers) and Cardiac Fibrosis and Remodeling (11 papers). Blanche Schroen collaborates with scholars based in Netherlands, Belgium and United States. Blanche Schroen's co-authors include Stéphane Heymans, Yigal M. Pinto, Maarten F. Corsten, Jos G. Maessen, Jack P.M. Cleutjens, Yvan Devaux, Daniel R. Wagner, Mark W.M. Schellings, Saraswati Pokharel and Harry J.G.M. Crijns and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and The Journal of Experimental Medicine.

In The Last Decade

Blanche Schroen

61 papers receiving 5.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Galectin-3 Marks Activated Macrophages in Failure-Prone Hypertrophied Hearts and Contributes to Cardiac Dysfunction

2004 735 citations Jack P.M. Cleutjens, Blanche Schroen et al. Circulation profile →
miR-133 and miR-30 Regulate Connective Tissue Growth Factor

2008 700 citations Blanche Schroen, Mark W.M. Schellings et al. profile →
Circulating MicroRNA-208b and MicroRNA-499 Reflect Myocardial Damage in Cardiovascular Disease

2010 638 citations Maarten F. Corsten, Robert Dennert et al. Circulation Cardiovascular Genetics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Blanche Schroen Netherlands	32	3.4k	2.7k	1.9k	836	652	63	5.5k
Fatih Arslan Netherlands	28	4.8k 1.4×	2.2k 0.8×	1.5k 0.8×	863 1.0×	1.5k 2.3×	61	7.2k
Mihail Hristov Germany	29	3.1k 0.9×	1.5k 0.6×	517 0.3×	1.1k 1.3×	778 1.2×	43	4.8k
Lars Mäegdefessel Germany	42	2.7k 0.8×	1.8k 0.7×	866 0.4×	1.5k 1.8×	1.0k 1.6×	163	5.6k
Bénédicte Hugel France	24	2.3k 0.7×	606 0.2×	882 0.5×	1.2k 1.5×	417 0.6×	25	4.2k
Margreet R. de Vries Netherlands	39	1.9k 0.6×	807 0.3×	654 0.3×	1.3k 1.6×	1.2k 1.9×	146	4.5k
Marcin Dobaczewski United States	21	2.1k 0.6×	459 0.2×	2.5k 1.3×	548 0.7×	917 1.4×	26	4.5k
Hetty C. de Boer Netherlands	33	1.7k 0.5×	749 0.3×	518 0.3×	663 0.8×	518 0.8×	73	3.7k
Elena Rabkin United States	21	1.6k 0.5×	1.3k 0.5×	2.0k 1.1×	900 1.1×	2.6k 4.0×	21	5.7k
Emmanouil Chavakis Germany	27	2.6k 0.8×	1.3k 0.5×	325 0.2×	697 0.8×	640 1.0×	36	4.1k
Jaikirshan Khatri United States	9	760 0.2×	1.2k 0.5×	842 0.4×	587 0.7×	958 1.5×	44	3.4k

Countries citing papers authored by Blanche Schroen

Since Specialization

Citations

This map shows the geographic impact of Blanche Schroen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Blanche Schroen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Blanche Schroen more than expected).

Fields of papers citing papers by Blanche Schroen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Blanche Schroen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Blanche Schroen. The network helps show where Blanche Schroen may publish in the future.

Co-authorship network of co-authors of Blanche Schroen

This figure shows the co-authorship network connecting the top 25 collaborators of Blanche Schroen. A scholar is included among the top collaborators of Blanche Schroen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Blanche Schroen. Blanche Schroen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nieuwenhoven, Frans A. van, et al.. (2023). Plasma Extracellular Vesicles as Liquid Biopsy to Unravel the Molecular Mechanisms of Cardiac Reverse Remodeling Following Resynchronization Therapy?. Journal of Clinical Medicine. 12(2). 665–665. 1 indexed citations

Suthahar, Navin, Laura M G Meems, Dirk J. van Veldhuisen, et al.. (2020). High-Sensitivity Troponin-T and Cardiovascular Outcomes in the Community: Differences Between Women and Men. Mayo Clinic Proceedings. 95(6). 1158–1168. 11 indexed citations

Verjans, Robin, Wouter Derks, Kerstin Korn, et al.. (2019). Functional Screening Identifies MicroRNAs as Multi-Cellular Regulators of Heart Failure. Scientific Reports. 9(1). 6055–6055. 29 indexed citations

Micheletti, Rudi, Isabelle Plaisance, Brian J. Abraham, et al.. (2017). The long noncoding RNA Wisper controls cardiac fibrosis and remodeling. Science Translational Medicine. 9(395). 249 indexed citations

Micheletti, Rudi, Isabelle Plaisance, Brian J. Abraham, et al.. (2017). The long noncoding RNA Wisper controls cardiac fibrosis and remodeling. DSpace@MIT (Massachusetts Institute of Technology). 24 indexed citations

Verjans, Robin, Marc van Bilsen, & Blanche Schroen. (2017). MiRNA Deregulation in Cardiac Aging and Associated Disorders. International review of cell and molecular biology. 334. 207–263. 27 indexed citations

Caron, Marjolein M. J., Don A. M. Surtel, Ekkehart Lausch, et al.. (2017). Expression of RMRP RNA is regulated in chondrocyte hypertrophy and determines chondrogenic differentiation. Scientific Reports. 7(1). 6440–6440. 35 indexed citations

McDermott‐Roe, Chris, Marion Leleu, Glenn C. Rowe, et al.. (2017). Transcriptome-wide co-expression analysis identifies LRRC2 as a novel mediator of mitochondrial and cardiac function. PLoS ONE. 12(2). e0170458–e0170458. 9 indexed citations

Peters, T. J., Abdelaziz Beqqali, Nicole Bitsch, et al.. (2016). Long Non-Coding RNA Malat-1 Is Dispensable during Pressure Overload-Induced Cardiac Remodeling and Failure in Mice. PLoS ONE. 11(2). e0150236–e0150236. 36 indexed citations

10.

Aelst, Lucas Van, Georg Summer, Shengqiao Li, et al.. (2015). RNA Profiling in Human and Murine Transplanted Hearts: Identification and Validation of Therapeutic Targets for Acute Cardiac and Renal Allograft Rejection. American Journal of Transplantation. 16(1). 99–110. 47 indexed citations

11.

Heggermont, Ward, Anna‐Pia Papageorgiou, Annelies Quaegebeur, et al.. (2014). MicroRNA-146a interferes with TCA cycle flux via DLST and rewires cardiomyocyte metabolism in hypertensive heart failure. European Journal of Heart Failure. 16. 102–102. 1 indexed citations

12.

Poller, Wolfgang, Martina Gast, Blanche Schroen, et al.. (2014). Abstract 11247: The Long Noncoding MALAT1 - MascRNA System is a Novel Regulator of Cardiac Innate Immunity. Circulation. 130. 1 indexed citations

13.

Peters, T. J. & Blanche Schroen. (2014). Missing links in cardiology: long non-coding RNAs enter the arena. Pflügers Archiv - European Journal of Physiology. 466(6). 1177–1187. 17 indexed citations

14.

Schroen, Blanche, Maarten F. Corsten, Wouter Verhesen, et al.. (2012). Absence of microRNA-155 protects against adverse cardiac inflammation and hypertrophy during pressure overload and prevents heart failure. Cardiovascular Research. 93. 2 indexed citations

15.

Heggermont, Ward, Paolo Carai, Lucas Van Aelst, et al.. (2012). Micro-RNA 146a: a new kid on the block in the pathophysiology of cardiac hypertrophy and hypertensive heart failure, and a promising therapeutic target. European Heart Journal Supplements. 33. 115–115. 1 indexed citations

16.

Vrie, M. van de, Stéphane Heymans, & Blanche Schroen. (2011). MicroRNA Involvement in Immune Activation During Heart Failure. Cardiovascular Drugs and Therapy. 25(2). 161–170. 33 indexed citations

17.

Almen, Geert C. van, Wouter Verhesen, Rick E.W. van Leeuwen, et al.. (2011). MicroRNA‐18 and microRNA‐19 regulate CTGF and TSP‐1 expression in age‐related heart failure. Aging Cell. 10(5). 769–779. 212 indexed citations

18.

Almen, Geert C. van, Melissa Swinnen, Paolo Carai, et al.. (2011). Absence of thrombospondin-2 increases cardiomyocyte damage and matrix disruption in doxorubicin-induced cardiomyopathy. Journal of Molecular and Cellular Cardiology. 51(3). 318–328. 41 indexed citations

19.

Corsten, Maarten F., Robert Dennert, Sylvia H. J. Jochems, et al.. (2010). Circulating MicroRNA-208b and MicroRNA-499 Reflect Myocardial Damage in Cardiovascular Disease. Circulation Cardiovascular Genetics. 3(6). 499–506. 638 indexed citations breakdown →

20.

Aelst, Lucas Van, Melissa Swinnen, Davy Vanhoutte, et al.. (2010). Mimecan is an essential regulator of extracellular matrix integrity after myocardial infarction. European Journal of Heart Failure Supplements. 9. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact